Literature DB >> 7650378

Organization, regulatory sequences, and alternatively spliced transcripts of the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) gene.

S O Sampaio1, X Li, M Takeuchi, C Mei, U Francke, E C Butcher, M J Briskin.   

Abstract

The mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is expressed selectively at venular sites of lymphocyte extravasation into mucosal lymphoid tissues and lamina propria, where it directs local lymphocyte trafficking. MAdCAM-1 is a multifunctional type l transmembrane adhesion molecule comprising two distal lg domains involved in alpha 4 beta 7 integrin binding, a mucin-like region able to display L-selectin-binding carbohydrates, and a membrane-proximal lg domain homologous to lgA. We show in this work that the MAdCAM-1 gene is located on chromosome 10 and contains five exons. The signal peptide and each one of the three lg domains are encoded by a distinct exon, whereas the transmembrane, cytoplasmic tail, and 3'-untranslated region of MAdCAM-1 are combined on a single exon. The mucin-like region and the third lg domain are encoded together on exon 4. An alternatively spliced MAdCAM-1 mRNA is identified that lacks the mucin/lgA-homologous exon 4-encoded sequences. This short variant of MAdCAM-1 may be specialized to support alpha 4 beta 7-dependent adhesion strengthening, independent of carbohydrate-presenting function. Sequences 5' of the transcription start site include tandem nuclear factor-kappa B sites; AP-1, AP-2, and signal peptide-1 binding sites; and an estrogen response element. Our findings reinforce the correspondence between the multidomain structure and versatile functions of this vascular addressin, and suggest an additional level of regulation of carbohydrate-presenting capability, and thus of its importance in lectin-mediated vs alpha 4 beta 7-dependent adhesive events in lymphocyte trafficking.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.

Authors:  Natalia Guerra-Pérez; Ines Frank; Filippo Veglia; Meropi Aravantinou; Diana Goode; James L Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

Review 2.  Mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Its binding motif for alpha 4 beta 7 and role in experimental colitis.

Authors:  S Fong; S Jones; M E Renz; H H Chiu; A M Ryan; L G Presta; D Jackson
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue.

Authors:  O Pabst; R Förster; M Lipp; H Engel; H H Arnold
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

4.  Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin.

Authors:  G M Walsh; F A Symon; A L Lazarovils; A J Wardlaw
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

5.  Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.

Authors:  J U Igietseme; J L Portis; L L Perry
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 6.  Glycosylation in immune cell trafficking.

Authors:  Markus Sperandio; Christian A Gleissner; Klaus Ley
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

7.  Mucosal addressin cell adhesion molecule-1 of rhesus macaques: molecular cloning, expression, and alteration after viral infection.

Authors:  Yue Wang; Wen-Rong Yao; Jia-Zhong Duan; Wei Xu; Gui-Bo Yang
Journal:  Dig Dis Sci       Date:  2014-05-15       Impact factor: 3.199

8.  TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide.

Authors:  T Oshima; P Jordan; M B Grisham; J S Alexander; M Jennings; M Sasaki; K Manas
Journal:  BMC Gastroenterol       Date:  2001-07-12       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.